4.8 Article

Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2123000119

Keywords

SARS-CoV-2/COVID-19; genetic variation; phenotype association; natural selection; African diversity

Funding

  1. National Heart, Lung and Blood Institute (NHLBI)
  2. TOPMed Informatics Research Center [3R01HL-117626-02S1, HHSN268201800002I, R01LM010098, X01HL139409, 1R35GM134957, R01GM113657, R01DK104339, R01AR076241, R01GM138597]
  3. NIH [R01HL-120393, U01HL-120393, HHSN268201800001I, R35GM138201]
  4. ADA [1-19-VSN-02]
  5. American Institute of Chemical Engineers Foundation
  6. Defense Threat Reduction Agency (DTRA) [HDTRA11810041, HDTRA1-21-1-0014]
  7. Health-Tech Accelerator Award
  8. Nemirovsky Prize
  9. Institute for Diabetes, Obesity, and Metabolism
  10. Mental Health AIDS Research Center
  11. Dean's Innovation Fund from the Perelman School of Medicine at the University of Pennsylvania
  12. Perelman School of Medicine at University of Pennsylvania
  13. National Center for Advancing Translational Sciences of the NIH under CTSA [UL1TR001878]

Ask authors/readers for more resources

This study investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection. The study found variants in ACE2 and TMPRSS2 genes that impact SARS-CoV-2 infection, with some variants being influenced by natural selection in specific populations. These findings provide insights into global variation at host genes related to SARS-CoV-2 infection.
Human genomic diversity has been shaped by both ancient and ongoing challenges from viruses. The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a devastating impact on population health. However, genetic diversity and evolutionary forces impacting host genes related to SARS-CoV-2 infection are not well understood. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection (angiotensin converting enzyme 2 [ACE2], transmembrane protease serine 2 [TMPRSS2], dipeptidyl peptidase 4 [DPP4], and lymphocyte antigen 6 complex locus E [LY6E]). We analyzed data from 2,012 ethnically diverse Africans and 15,977 individuals of European and African ancestry with electronic health records and integrated with global data from the 1000 Genomes Project. At ACE2, we identified 41 nonsynonymous variants that were rare in most populations, several of which impact protein function. However, three nonsynonymous variants (rs138390800, rs147311723, and rs145437639) were common among central African hunter-gatherers from Cameroon (minor allele frequency 0.083 to 0.164) and are on haplotypes that exhibit signatures of positive selection. We identify signatures of selection impacting variation at regulatory regions influencing ACE2 expression in multiple African populations. At TMPRSS2, we identified 13 amino acid changes that are adaptive and specific to the human lineage compared with the chimpanzee genome. Genetic variants that are targets of natural selection are associated with clinical phenotypes common in patients with COVID-19. Our study provides insights into global variation at host genes related to SARS-CoV-2 infection, which have been shaped by natural selection in some populations, possibly due to prior viral infections.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available